Did you know that traditional Cardiopulmonary Exercise Testing (CPET) can cost hundreds of dollars per session and often requires bulky equipment and hospital visits? For many runners, this makes ...
Pharmacodynamic separation (PDS) of gemcitabine (Gem) and the epidermal growth factor receptor (EGFR) inhibitor erlotinib (E) in patients (Pts) with advanced pancreatic cancer: Phase II results. This ...
In a recent study posted to the medRxiv* pre-print server, researchers demonstrated reduced exercise capacity due to persistent cardiopulmonary symptoms among coronavirus disease 2019 (COVID-19) ...
For cardiopulmonary exercise testing (CPET), patients exercise on either a stationary bike or a treadmill. Cardiac, respiratory, and metabolic function are measured during warm-up and then during ...
"ATTR amyloidosis was characterized by distinct patterns of functional impairment across all disease phenotypes, attributable to multiple physiological mechanisms. Multiple CPET parameters were ...
Cardiopulmonary exercise testing (CPET), also known as ergospirometry, can be used for early detection of respiratory disorders in overweight and obese individuals. This is the main finding of a study ...
Correspondence to Dr Robert I Liem, Division of Hematology, Oncology & Stem Cell Transplant, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA; rliem{at}luriechildrens.org ...
Patients who have unexplained dyspnea months after recovering from COVID-19 often have objective signs of breathing problems on cardiopulmonary exercise testing (CPET) and meet criteria for myalgic ...
Many patients with symptoms of long COVID have reduced exercise capacity, which if better understood might be helpful in managing their treatment, according to a systematic review and meta-analysis of ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Individuals who continue to experience shortness of breath post-acute COVID-19 despite normal chest ...
Osteonecrosis of the jaw in metastatic renal cell carcinoma (mRCC) patients treated with zolendronic acid and denosumab: An observational retrospective multicenter trial. Efficacy and safety of ...